Guardant Health Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 10, 2022 / 09:00PM GMT
Elizabeth Cristina Mari Garcia - UBS Investment Bank, Research Division - US Life Science Analyst

Thanks so much. You've got Liza Garcia here, UBS Life Science Tools and Diagnostics with John Sourbeer, and we are very, very fortunate. We have here AmirAli from Guardant, Co-CEO. He will be joining us for a panel on liquid biopsy and all the exciting things that Guardant is doing at the moment. And so thank you very much, and welcome.

AmirAli Talasaz - Guardant Health, Inc. - Co-CEO & Director

Thanks for having me.

Elizabeth Cristina Mari Garcia - UBS Investment Bank, Research Division - US Life Science Analyst

Well, let's start off, I guess, is kind of something top of mind, reimbursement win for Reveal at the beginning of the month. Obviously, yours has a little bit different than maybe some of the other colorectal MRD tests in the market. So I was hoping you could kind of update us on the reimbursement amount that you have with Medicare. For Reveal as the only blood-only offering and kind of where it stands,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot